Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2017 4
2018 143
2019 265
2020 182
2021 34
Text availability
Article attribute
Article type
Publication date

Search Results

552 results
Results by year
Filters applied: . Clear all
Page 1
Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis.
Drolet M, Bénard É, Pérez N, Brisson M; HPV Vaccination Impact Study Group. Drolet M, et al. Lancet. 2019 Aug 10;394(10197):497-509. doi: 10.1016/S0140-6736(19)30298-3. Epub 2019 Jun 26. Lancet. 2019. PMID: 31255301 Free PMC article.
BACKGROUND: More than 10 years have elapsed since human papillomavirus (HPV) vaccination was implemented. We did a systematic review and meta-analysis of the population-level impact of vaccinating girls and women against human papillomavirus on …
BACKGROUND: More than 10 years have elapsed since human papillomavirus (HPV) vaccination was implemented. We did a syst …
HPV vaccination in HIV infection.
Lacey CJ. Lacey CJ. Papillomavirus Res. 2019 Dec;8:100174. doi: 10.1016/j.pvr.2019.100174. Epub 2019 Jun 25. Papillomavirus Res. 2019. PMID: 31252073 Free PMC article. Review.
Persons with HIV are at increased risk of HPV infection, HPV disease, and HPV-related cancers compared to HIV negative persons. In persons with HIV, immune responses to vaccination are often sub-optimal, and while these improve with ART, they often rem …
Persons with HIV are at increased risk of HPV infection, HPV disease, and HPV-related cancers compared to HIV ne …
Disparities in HPV vaccination rates and HPV prevalence in the United States: a review of the literature.
Hirth J. Hirth J. Hum Vaccin Immunother. 2019;15(1):146-155. doi: 10.1080/21645515.2018.1512453. Epub 2018 Sep 6. Hum Vaccin Immunother. 2019. PMID: 30148974 Free PMC article. Review.
Human papillomavirus (HPV) is a common sexually transmitted infection which is the cause of several cancers, including cervical cancer, and genital warts. Although cervical cancer can be prevented through screening, this cancer persists in the US. More
Human papillomavirus (HPV) is a common sexually transmitted infection which is the cause of several cancers, including
Screening for Cervical Cancer.
Eun TJ, Perkins RB. Eun TJ, et al. Med Clin North Am. 2020 Nov;104(6):1063-1078. doi: 10.1016/j.mcna.2020.08.006. Med Clin North Am. 2020. PMID: 33099451 Review.
The most effective strategy for cervical cancer prevention involves vaccination to prevent human papillomavirus (HPV) infections during adolescence followed by screening to detect HPV infections during adulthood. HPV vaccination be …
The most effective strategy for cervical cancer prevention involves vaccination to prevent human papillomavirus
Cervical Cancer Screening Programs in Europe: The Transition Towards HPV Vaccination and Population-Based HPV Testing.
Chrysostomou AC, Stylianou DC, Constantinidou A, Kostrikis LG. Chrysostomou AC, et al. Viruses. 2018 Dec 19;10(12):729. doi: 10.3390/v10120729. Viruses. 2018. PMID: 30572620 Free PMC article. Review.
Since the development of the Papanicolaou (Pap) test, screening has been essential in identifying cervical cancer at a treatable stage. With the identification of the human papillomavirus (HPV) as the causative agent of essentially all cervical cancer cases, …
Since the development of the Papanicolaou (Pap) test, screening has been essential in identifying cervical cancer at a treatable stage. With …
Human Papillomavirus Vaccines: Successes and Future Challenges.
Perez S, Zimet GD, Tatar O, Stupiansky NW, Fisher WA, Rosberger Z. Perez S, et al. Drugs. 2018 Sep;78(14):1385-1396. doi: 10.1007/s40265-018-0975-6. Drugs. 2018. PMID: 30269207 Review.
Over a decade has passed since the first human papillomavirus (HPV) vaccine was introduced. These vaccines have received unequivocal backing from the scientific and medical communities, yet continue to be debated in the media and within the general public. .. …
Over a decade has passed since the first human papillomavirus (HPV) vaccine was introduced. These vaccines have receive …
Screening for Cervical Cancer.
Ngo-Metzger Q, Adsul P. Ngo-Metzger Q, et al. Am Fam Physician. 2019 Feb 15;99(4):253-254. Am Fam Physician. 2019. PMID: 30763054 Free article. Review. No abstract available.
Human Papillomavirus Vaccine Effectiveness and Herd Protection in Young Women.
Spinner C, Ding L, Bernstein DI, Brown DR, Franco EL, Covert C, Kahn JA. Spinner C, et al. Pediatrics. 2019 Feb;143(2):e20181902. doi: 10.1542/peds.2018-1902. Epub 2019 Jan 22. Pediatrics. 2019. PMID: 30670582 Free PMC article.
BACKGROUND: Clinical trials of the 4-valent human papillomavirus (HPV) vaccine demonstrate high efficacy, but surveillance studies are essential to examine the long-term impact of vaccine introduction on HPV prevalence in community settings. ...METHODS …
BACKGROUND: Clinical trials of the 4-valent human papillomavirus (HPV) vaccine demonstrate high efficacy, but surveilla …
Infection and vaccine-induced HPV-specific antibodies in cervicovaginal secretions. A review of the literature.
Pattyn J, Van Keer S, Tjalma W, Matheeussen V, Van Damme P, Vorsters A. Pattyn J, et al. Papillomavirus Res. 2019 Dec;8:100185. doi: 10.1016/j.pvr.2019.100185. Epub 2019 Sep 5. Papillomavirus Res. 2019. PMID: 31494291 Free PMC article. Review.
BACKGROUND: Human papillomavirus (HPV) infects and propagates in the cervical mucosal epithelium. ...RESULTS: The systematic search and selection process yielded 44 articles. The evidence of HPV-specific antibodies in CVS after natural infection (26/44 …
BACKGROUND: Human papillomavirus (HPV) infects and propagates in the cervical mucosal epithelium. ...RESULTS: The syste …
Prophylactic HPV vaccination after conization: A systematic review and meta-analysis.
Jentschke M, Kampers J, Becker J, Sibbertsen P, Hillemanns P. Jentschke M, et al. Vaccine. 2020 Sep 22;38(41):6402-6409. doi: 10.1016/j.vaccine.2020.07.055. Epub 2020 Aug 4. Vaccine. 2020. PMID: 32762871 Review.
INTRODUCTION: Human papillomavirus (HPV) vaccination is essential for cervical cancer prevention. ...RESULTS: Primary end point was CIN2+ in every study. The overall study population included 21,059 patients (3,939 vaccinations vs. 17,150 con
INTRODUCTION: Human papillomavirus (HPV) vaccination is essential for cervical cancer prevention. ...RESULTS: …
552 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page